Steven Lim

Array ( [id] => 5943551 [patent_doc_number] => 20110104171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'EphA4 Polypeptide Having a Novel Activity and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/986922 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33178 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104171.pdf [firstpage_image] =>[orig_patent_app_number] => 12986922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214753 [patent_doc_number] => 20110137013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'NOVEL COLLAGEN-LIKE PROTEIN CLAC, PRECURSOR THEREOF AND GENES ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/985917 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14306 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137013.pdf [firstpage_image] =>[orig_patent_app_number] => 12985917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657487 [patent_doc_number] => 20110306756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Prevention and Treatment of Amyloidogenic Disease' [patent_app_type] => utility [patent_app_number] => 12/977013 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32221 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306756.pdf [firstpage_image] =>[orig_patent_app_number] => 12977013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453696 [patent_doc_number] => 20120264642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID BETA PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/514825 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19804 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212311 [patent_doc_number] => 20110135611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHODS FOR TREATING APOLIPOPROTEIN E4-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/958052 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26945 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135611.pdf [firstpage_image] =>[orig_patent_app_number] => 12958052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102542 [patent_doc_number] => 20110166035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NOVEL DIAGNOSTIC METHOD' [patent_app_type] => utility [patent_app_number] => 12/954225 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23679 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166035.pdf [firstpage_image] =>[orig_patent_app_number] => 12954225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701161 [patent_doc_number] => 08394380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Compositions and methods for alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 12/945669 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22236 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12945669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031053 [patent_doc_number] => 20110081360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Human G-Protein Chemokine Receptor (CCR5) HDGNR10' [patent_app_type] => utility [patent_app_number] => 12/943722 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 180004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081360.pdf [firstpage_image] =>[orig_patent_app_number] => 12943722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024285 [patent_doc_number] => 20110052611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'PEPTIDE CONJUGATE COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/907493 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052611.pdf [firstpage_image] =>[orig_patent_app_number] => 12907493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201948 [patent_doc_number] => 20110064734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/940750 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41766 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064734.pdf [firstpage_image] =>[orig_patent_app_number] => 12940750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055920 [patent_doc_number] => 20110112280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'USE OF RGM AND ITS MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/939823 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15140 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112280.pdf [firstpage_image] =>[orig_patent_app_number] => 12939823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102836 [patent_doc_number] => 20110166329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Combinations of SAP depleting agents and anti-SAP antibodies' [patent_app_type] => utility [patent_app_number] => 12/916378 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28525 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166329.pdf [firstpage_image] =>[orig_patent_app_number] => 12916378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521668 [patent_doc_number] => 09605054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Composition and method for treating a tauopathy' [patent_app_type] => utility [patent_app_number] => 12/906617 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9818 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12906617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335050 [patent_doc_number] => 20120201757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'MUTANT LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN WITH INCREASED BINDING TO ALZHEIMER AMYLOID-BETA PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/501877 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10232 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943561 [patent_doc_number] => 20110104181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'MODULATION OF SYNAPTOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/905930 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 34727 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104181.pdf [firstpage_image] =>[orig_patent_app_number] => 12905930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574023 [patent_doc_number] => 20110269679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'INHIBITORS OF AMYLOID FIBRIL FORMATION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/905773 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13872 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269679.pdf [firstpage_image] =>[orig_patent_app_number] => 12905773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8532935 [patent_doc_number] => 08309088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Method of treating osteoarthritis with an antibody to NGF' [patent_app_type] => utility [patent_app_number] => 12/888751 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13816 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12888751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038861 [patent_doc_number] => 20110091910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'NOVEL ASSAY' [patent_app_type] => utility [patent_app_number] => 12/884403 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21577 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091910.pdf [firstpage_image] =>[orig_patent_app_number] => 12884403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863455 [patent_doc_number] => 08889144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'PCSK9 vaccine' [patent_app_type] => utility [patent_app_number] => 12/872645 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37015 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12872645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312612 [patent_doc_number] => 20120189636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'HUMAN SERUM AMYLOID-A3 ANTIBODY AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/499781 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4635 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499781 [rel_patent_id] =>[rel_patent_doc_number] =>)